Literature DB >> 26136511

Acyl-CoA synthetase 1 deficiency alters cardiolipin species and impairs mitochondrial function.

Trisha J Grevengoed1, Sarah A Martin2, Lalage Katunga3, Daniel E Cooper1, Ethan J Anderson3, Robert C Murphy2, Rosalind A Coleman1.   

Abstract

Long-chain acyl-CoA synthetase 1 (ACSL1) contributes more than 90% of total cardiac ACSL activity, but its role in phospholipid synthesis has not been determined. Mice with an inducible knockout of ACSL1 (Acsl1(T-/-)) have impaired cardiac fatty acid oxidation and rely on glucose for ATP production. Because ACSL1 exhibited a strong substrate preference for linoleate, we investigated the composition of heart phospholipids. Acsl1(T-/-) hearts contained 83% less tetralinoleoyl-cardiolipin (CL), the major form present in control hearts. A stable knockdown of ACSL1 in H9c2 rat cardiomyocytes resulted in low incorporation of linoleate into CL and in diminished incorporation of palmitate and oleate into other phospholipids. Overexpression of ACSL1 in H9c2 and HEK-293 cells increased incorporation of linoleate into CL and other phospholipids. To determine whether increasing the content of linoleate in CL would improve mitochondrial respiratory function in Acsl1(T-/-) hearts, control and Acsl1(T-/-) mice were fed a high-linoleate diet; this diet normalized the amount of tetralinoleoyl-CL but did not improve respiratory function. Thus, ACSL1 is required for the normal composition of several phospholipid species in heart. Although ACSL1 determines the acyl-chain composition of heart CL, a high tetralinoleoyl-CL content may not be required for normal function.
Copyright © 2015 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  cardiomyocyte dysfunction; fatty acid/oxidation; heart fatty acid/metabolism; phospholipids/biosynthesis; phospholipids/metabolism

Mesh:

Substances:

Year:  2015        PMID: 26136511      PMCID: PMC4513998          DOI: 10.1194/jlr.M059717

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  43 in total

Review 1.  The versatility of mitochondrial calcium signals: from stimulation of cell metabolism to induction of cell death.

Authors:  Alessandro Rimessi; Carlotta Giorgi; Paolo Pinton; Rosario Rizzuto
Journal:  Biochim Biophys Acta       Date:  2008 Jul-Aug

2.  Quantitation of cardiolipin molecular species in spontaneously hypertensive heart failure rats using electrospray ionization mass spectrometry.

Authors:  Genevieve C Sparagna; Chris A Johnson; Sylvia A McCune; Russell L Moore; Robert C Murphy
Journal:  J Lipid Res       Date:  2005-03-16       Impact factor: 5.922

3.  Identification and characterization of human cardiolipin synthase.

Authors:  Riekelt H Houtkooper; Hana Akbari; Henk van Lenthe; Willem Kulik; Ronald J A Wanders; Margrit Frentzen; Frédéric M Vaz
Journal:  FEBS Lett       Date:  2006-04-27       Impact factor: 4.124

4.  Mouse cardiac acyl coenzyme a synthetase 1 deficiency impairs Fatty Acid oxidation and induces cardiac hypertrophy.

Authors:  Jessica M Ellis; Shannon M Mentock; Michael A Depetrillo; Timothy R Koves; Shiraj Sen; Steven M Watkins; Deborah M Muoio; Gary W Cline; Heinrich Taegtmeyer; Gerald I Shulman; Monte S Willis; Rosalind A Coleman
Journal:  Mol Cell Biol       Date:  2011-01-18       Impact factor: 4.272

5.  Cardiac and skeletal muscle defects in a mouse model of human Barth syndrome.

Authors:  Devrim Acehan; Frederic Vaz; Riekelt H Houtkooper; Jeanne James; Vicky Moore; Chonan Tokunaga; Willem Kulik; Janaka Wansapura; Matthew J Toth; Arnold Strauss; Zaza Khuchua
Journal:  J Biol Chem       Date:  2010-11-09       Impact factor: 5.157

6.  Deficiency of tetralinoleoyl-cardiolipin in Barth syndrome.

Authors:  Michael Schlame; Jeffrey A Towbin; Paul M Heerdt; Roswitha Jehle; Salvatore DiMauro; Thomas J J Blanck
Journal:  Ann Neurol       Date:  2002-05       Impact factor: 10.422

7.  Cardiac energy dependence on glucose increases metabolites related to glutathione and activates metabolic genes controlled by mechanistic target of rapamycin.

Authors:  Jonathan C Schisler; Trisha J Grevengoed; Florencia Pascual; Daniel E Cooper; Jessica M Ellis; David S Paul; Monte S Willis; Cam Patterson; Wei Jia; Rosalind A Coleman
Journal:  J Am Heart Assoc       Date:  2015-02-24       Impact factor: 5.501

8.  Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins.

Authors:  Hui-Hua Li; Monte S Willis; Pamela Lockyer; Nathaniel Miller; Holly McDonough; David J Glass; Cam Patterson
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

9.  Tafazzin knockdown in mice leads to a developmental cardiomyopathy with early diastolic dysfunction preceding myocardial noncompaction.

Authors:  Colin K L Phoon; Devrim Acehan; Michael Schlame; David L Stokes; Irit Edelman-Novemsky; Dawen Yu; Yang Xu; Nitya Viswanathan; Mindong Ren
Journal:  J Am Heart Assoc       Date:  2012-04-24       Impact factor: 5.501

10.  Cardiolipin provides an essential activating platform for caspase-8 on mitochondria.

Authors:  Francois Gonzalvez; Zachary T Schug; Riekelt H Houtkooper; Elaine D MacKenzie; David G Brooks; Ronald J A Wanders; Patrice X Petit; Frédéric M Vaz; Eyal Gottlieb
Journal:  J Cell Biol       Date:  2008-11-10       Impact factor: 10.539

View more
  21 in total

1.  Long-chain acyl-CoA synthetase 1 interacts with key proteins that activate and direct fatty acids into niche hepatic pathways.

Authors:  Pamela A Young; Can E Senkal; Amanda L Suchanek; Trisha J Grevengoed; Dennis D Lin; Liyang Zhao; Amanda E Crunk; Eric L Klett; Joachim Füllekrug; Lina M Obeid; Rosalind A Coleman
Journal:  J Biol Chem       Date:  2018-09-06       Impact factor: 5.157

2.  Defective fatty acid oxidation in mice with muscle-specific acyl-CoA synthetase 1 deficiency increases amino acid use and impairs muscle function.

Authors:  Liyang Zhao; Florencia Pascual; Lawrence Bacudio; Amanda L Suchanek; Pamela A Young; Lei O Li; Sarah A Martin; Joao-Paulo Camporez; Rachel J Perry; Gerald I Shulman; Eric L Klett; Rosalind A Coleman
Journal:  J Biol Chem       Date:  2019-04-11       Impact factor: 5.157

Review 3.  Physiological Consequences of Compartmentalized Acyl-CoA Metabolism.

Authors:  Daniel E Cooper; Pamela A Young; Eric L Klett; Rosalind A Coleman
Journal:  J Biol Chem       Date:  2015-06-29       Impact factor: 5.157

4.  Response by Lewandowski et al to Letter Regarding Article, "Preservation of Acyl Coenzyme A Attenuates Pathological and Metabolic Cardiac Remodeling Through Selective Lipid Trafficking".

Authors:  E Douglas Lewandowski; Joseph R Goldenberg; Andrew N Carley; P Christian Schulze
Journal:  Circulation       Date:  2019-11-04       Impact factor: 29.690

5.  Preservation of Acyl Coenzyme A Attenuates Pathological and Metabolic Cardiac Remodeling Through Selective Lipid Trafficking.

Authors:  Joseph R Goldenberg; Andrew N Carley; Ruiping Ji; Xiaokan Zhang; Matt Fasano; P Christian Schulze; E Douglas Lewandowski
Journal:  Circulation       Date:  2019-03-26       Impact factor: 29.690

Review 6.  The role of cardiolipin concentration and acyl chain composition on mitochondrial inner membrane molecular organization and function.

Authors:  Edward Ross Pennington; Katsuhiko Funai; David A Brown; Saame Raza Shaikh
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2019-04-02       Impact factor: 4.698

7.  Long-chain acyl-CoA synthetase isoforms differ in preferences for eicosanoid species and long-chain fatty acids.

Authors:  Eric L Klett; Shufen Chen; Alekhya Yechoor; Fred B Lih; Rosalind A Coleman
Journal:  J Lipid Res       Date:  2017-02-16       Impact factor: 5.922

Review 8.  Fuel availability and fate in cardiac metabolism: A tale of two substrates.

Authors:  Florencia Pascual; Rosalind A Coleman
Journal:  Biochim Biophys Acta       Date:  2016-03-16

9.  Proteolipid domains form in biomimetic and cardiac mitochondrial vesicles and are regulated by cardiolipin concentration but not monolyso-cardiolipin.

Authors:  Edward Ross Pennington; E Madison Sullivan; Amy Fix; Sahil Dadoo; Tonya N Zeczycki; Anita DeSantis; Uwe Schlattner; Rosalind A Coleman; Adam J Chicco; David A Brown; Saame Raza Shaikh
Journal:  J Biol Chem       Date:  2018-08-29       Impact factor: 5.157

Review 10.  Acyl-CoA synthetases as regulators of brain phospholipid acyl-chain diversity.

Authors:  Regina F Fernandez; Jessica M Ellis
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2020-09-15       Impact factor: 4.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.